Patents Assigned to GlobalAcornLtd.
  • Publication number: 20150119352
    Abstract: The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP-gated P2X3 receptor, often by means of high-affinity desensitisation (HAD) mechanism.
    Type: Application
    Filed: May 24, 2013
    Publication date: April 30, 2015
    Applicant: GlobalAcornLtd.
    Inventors: Andrew David Miller, Natalya Lozovaya, Nail Burnashev, Rashid Giniatullin